FDA Calls for Nominations for TPSAC Members.

Sep.27.2022
FDA Calls for Nominations for TPSAC Members.
The FDA is seeking nominations for two individuals to serve on the Tobacco Products Scientific Advisory Committee.

The US Food and Drug Administration's Center for Tobacco Products is currently seeking nominations for two individuals to serve as voting members of the Tobacco Product Scientific Advisory Committee (TPSAC). According to the FDA website, individuals are able to self-nominate or be nominated by any interested person or organization.


Source: Postmodern Studio


Nominations received by November 25, 2022 or before will be given priority consideration. Nominations received after November 25, 2022 will be considered for future openings.


The Tobacco Products Scientific Advisory Committee (TPSAC) provides advice to the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration (FDA) regarding its responsibilities in regulating tobacco products. The committee reviews and evaluates tobacco product safety, dependence, and health issues, and provides appropriate recommendations, information, and advice to the FDA Commissioner.


This notice has been published in the Federal Gazette.


Disclaimer:


This article is compiled from third-party information and is intended for industry discussions and learning purposes only.


This article does not reflect the views of 2FIRSTS, nor can 2FIRSTS confirm the truthfulness and accuracy of the article's content. The translation of this article is only intended for communication and research purposes within the industry.


Due to limitations in the translator's proficiency, the translated article may not accurately convey the original meaning. Therefore, it is recommended to refer to the original article for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan or international issues, 2FIRSTS maintains complete alignment with the Chinese government's statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.